Hot Investor Mandate: Asia Cross Border VC Firm Invests in Therapeutics, Devices, and Diagnostics, Open to USA & China-Based Companies

8 Apr

A venture capital firm headquartered in Taiwan currently manages a fund focuses 50% on bio & healthcare-related investments, and outside of life sciences the firm invests in all types of high potential technologies with disruptive potential. The firm primarily seeks investment opportunities in USA, China and Taiwan.

The firm is most interested in novel therapeutics, but also invests in medical devices and diagnostics. Within therapeutics, the firm has invested across various modalities, from traditional small molecule therapeutics to emerging therapies like immunotherapy and cell/gene therapy. The firm is open to pre-IND, early-stage opportunities given they have a valid proof of concept and address an area of unmet medical need. As for medical devices, the firm generally invests in 510k products and open to all types of devices that address unmet medical need.

The firm has no specific company or management team requirements. Though the firm is based in Taiwan, the firm does not require any sort of Taiwan angle or market potential when evaluating cross-border opportunities. The firm is open to leading and co-investing in investment rounds and will most likely seek board representation when acting as the lead investor.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: